BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32236885)

  • 1. Standardized Workflows Improve Colonoscopy Follow-Up After Abnormal Fecal Immunochemical Tests in a Safety-Net System.
    Issaka RB; Rachocki C; Huynh MP; Chen E; Somsouk M
    Dig Dis Sci; 2021 Mar; 66(3):768-774. PubMed ID: 32236885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.
    Issaka RB; Bell-Brown A; Snyder C; Atkins DL; Chew L; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    JAMA Netw Open; 2021 Aug; 4(8):e2120159. PubMed ID: 34374771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
    Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
    Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.
    Cusumano VT; Corona E; Partida D; Yang L; Yu C; May FP
    BMC Gastroenterol; 2020 Apr; 20(1):115. PubMed ID: 32306919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.
    Issaka RB; Singh MH; Oshima SM; Laleau VJ; Rachocki CD; Chen EH; Day LW; Sarkar U; Somsouk M
    Am J Gastroenterol; 2017 Feb; 112(2):375-382. PubMed ID: 28154400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
    Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
    J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience.
    Thamarasseril S; Bhuket T; Chan C; Liu B; Wong RJ
    J Community Health; 2017 Jun; 42(3):551-557. PubMed ID: 27796633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients.
    Schneider JL; Rivelli JS; Gruss I; Petrik AF; Nielson CM; Green BB; Coronado GD
    Am J Health Behav; 2020 Jul; 44(4):460-472. PubMed ID: 32553027
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center.
    Shareef F; Bharti B; Garcia-Bigley F; Hernandez M; Nodora J; Liu J; Ramers C; Nery JD; Marquez J; Moyano K; Rojas S; Arredondo E; Gupta S
    J Prim Care Community Health; 2024; 15():21501319241242571. PubMed ID: 38554066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.
    Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00010. PubMed ID: 30829917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of OC-Auto Micro 80 Fecal Immunochemical Test in an Integrated Academic-Community Health System.
    Durowoju L; Mathias PC; Bell-Brown A; Breit N; Liao HC; Burke W; Issaka RB
    J Clin Gastroenterol; 2024 Jul; 58(6):602-606. PubMed ID: 37983772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to ensure follow-up of positive fecal immunochemical tests: An international survey of screening programs.
    Selby K; Senore C; Wong M; May FP; Gupta S; Liang PS
    J Med Screen; 2021 Mar; 28(1):51-53. PubMed ID: 32054392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.
    Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.
    Oluloro A; Petrik AF; Turner A; Kapka T; Rivelli J; Carney PA; Saha S; Coronado GD
    J Community Health; 2016 Aug; 41(4):864-70. PubMed ID: 26874943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.
    Petrik AF; Keast E; Johnson ES; Smith DH; Coronado GD
    BMC Health Serv Res; 2020 Nov; 20(1):1028. PubMed ID: 33172444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.